ABSTRACT
Importance: Experimental data suggest that intravenous vitamin C may attenuate inflammation and vascular injury associated with sepsis and acute respiratory distress syndrome (ARDS). Objective: To determine the effect of intravenous vitamin C infusion on organ failure scores and biological markers of inflammation and vascular injury in patients with sepsis and ARDS. Design, Setting, and Participants: The CITRIS-ALI trial was a randomized, double-blind, placebo-controlled, multicenter trial conducted in 7 medical intensive care units in the United States, enrolling patients (N = 167) with sepsis and ARDS present for less than 24 hours. The study was conducted from September 2014 to November 2017, and final follow-up was January 2018. Interventions: Patients were randomly assigned to receive intravenous infusion of vitamin C (50 mg/kg in dextrose 5% in water, n = 84) or placebo (dextrose 5% in water only, n = 83) every 6 hours for 96 hours. Main Outcomes and Measures: The primary outcomes were change in organ failure as assessed by a modified Sequential Organ Failure Assessment score (range, 0-20, with higher scores indicating more dysfunction) from baseline to 96 hours, and plasma biomarkers of inflammation (C-reactive protein levels) and vascular injury (thrombomodulin levels) measured at 0, 48, 96, and 168 hours. Results: Among 167 randomized patients (mean [SD] age, 54.8 years [16.7]; 90 men [54%]), 103 (62%) completed the study to day 60. There were no significant differences between the vitamin C and placebo groups in the primary end points of change in mean modified Sequential Organ Failure Assessment score from baseline to 96 hours (from 9.8 to 6.8 in the vitamin C group [3 points] and from 10.3 to 6.8 in the placebo group [3.5 points]; difference, -0.10; 95% CI, -1.23 to 1.03; P = .86) or in C-reactive protein levels (54.1 vs 46.1 µg/mL; difference, 7.94 µg/mL; 95% CI, -8.2 to 24.11; P = .33) and thrombomodulin levels (14.5 vs 13.8 ng/mL; difference, 0.69 ng/mL; 95% CI, -2.8 to 4.2; P = .70) at 168 hours. Conclusions and Relevance: In this preliminary study of patients with sepsis and ARDS, a 96-hour infusion of vitamin C compared with placebo did not significantly improve organ dysfunction scores or alter markers of inflammation and vascular injury. Further research is needed to evaluate the potential role of vitamin C for other outcomes in sepsis and ARDS. Trial Registration: ClinicalTrials.gov Identifier: NCT02106975.
Subject(s)
Ascorbic Acid/administration & dosage , Multiple Organ Failure/prevention & control , Respiratory Distress Syndrome/drug therapy , Sepsis/drug therapy , Vitamins/administration & dosage , Adult , Aged , Ascorbic Acid/therapeutic use , Biomarkers/blood , C-Reactive Protein/analysis , Double-Blind Method , Female , Humans , Infusions, Intravenous , Intensive Care Units , Male , Middle Aged , Multiple Organ Failure/etiology , Organ Dysfunction Scores , Respiratory Distress Syndrome/complications , Respiratory Distress Syndrome/mortality , Sepsis/complications , Sepsis/mortality , Thrombomodulin/blood , Vitamins/therapeutic useABSTRACT
Caring for critically ill patients with acute and/or chronic liver dysfunction poses a unique challenge. Proper resuscitation and early consideration for transfer to liver transplant centers have resulted in improved outcomes. Liver support devices and cellular models have not yet shown mortality benefit, but they hold promise in the critical care of patients with liver disease. This article reviews pertinent anatomic and physiologic considerations of the liver in critical illness, followed by a selective review of associated organ dysfunction.
Subject(s)
Critical Care , Critical Illness , Hepatic Encephalopathy/therapy , Liver Diseases/complications , Liver Diseases/physiopathology , Blood Coagulation Disorders/etiology , Blood Coagulation Disorders/therapy , Cardiovascular Diseases/etiology , Cardiovascular Diseases/therapy , Critical Illness/therapy , Hepatic Encephalopathy/etiology , Hepatorenal Syndrome/therapy , Humans , Infections/diagnosis , Infections/drug therapy , Liver Diseases/etiology , Protein-Energy Malnutrition/etiology , Protein-Energy Malnutrition/therapy , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/therapy , Severity of Illness IndexABSTRACT
INTRODUCTION: Noise in the emergency department (ED) may be perceived to be high by both patients and nurses alike. This increased noise level is hypothesized to be responsible for communication interference and subsequent disruption of complex procedures and decision-making. The objective of this study is to quantify ambient noise level in an ED while obtaining coincident subjective surveys from nurses in the assessment of actual versus perceived noise. METHODS: Data collected from surveys of ED nurses on each of 3 different dates revealed that sound levels within the selected ED were consistently at or below 70 decibels (dB) of sound as measured by a sound level meter. This level of sound is of the same decibel of normal conversation at a 3-5 foot distance. Nurses surveyed overwhelmingly rated noise as "low" or "not loud" irrespective of a variance (though predominantly within a 10 dB range) in actual sound decibel measurements. RESULTS: Years of experience of work within emergency departments proved the most consistent predictor of nurses' opinions on the frequency with which noise levels within the ED were louder than they should be, with more experienced nurses all ranking noise levels as "frequently" or "always" louder than they should be. CONCLUSION: Individual variance existed in how nurses felt that noise level affected work function. ED nurses' perception of noise is perceived to be low and generally not interfering with their cognitive function.
